Erik van Meegen
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 4
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 5
- Pharmacology and Obesity Treatment 1
-
- Atrial Fibrillation Management and Outcomes 6
- Blood Pressure and Hypertension Studies 4
- Toxicology top 10%
- Biochemistry top 10%
-
- Vitamin K Research Studies 3
-
- Veterinary Pharmacology and Anesthesia 1
-
- Poisoning and overdose treatments 1
- Co-authors
- Bruno H. StrickerFrits R. RosendaalF.J.M. van der MeerFernie J. A. Penning‐van BeestTom SchalekampAnthonius de BoerToine C. G. EgbertsJanine Roijers
- Journals
- Clinical Pharmacology & Therapeutics (2 papers)Thrombosis and Haemostasis (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- NetherlandsUnited StatesGreece
In The Last Decade
Erik van Meegen
12 papers receiving 452 citations
Peers
Comparison fields: 5 of 51
- Internal Medicine 102
- Pharmacology 217
- Cardiology and Cardiovascular Medicine 245
- Toxicology 30
- Biochemistry 48
Countries citing papers authored by Erik van Meegen
This map shows the geographic impact of Erik van Meegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik van Meegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik van Meegen more than expected).
Fields of papers citing papers by Erik van Meegen
This network shows the impact of papers produced by Erik van Meegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik van Meegen. The network helps show where Erik van Meegen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erik van Meegen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 13 | |
| 2 | 2011 | 74 | |
| 3 | 2010 | 20 | |
| 4 | 2006 | 77 | |
| 5 | [Partial resistance to acenocoumarol and phenprocoumon caused by enzyme polymorphism]. | 2006 | 3 |
| 6 | 2003 | 70 | |
| 7 | 2002 | 40 | |
| 8 | 2002 | 9 | |
| 9 | 2001 | 36 | |
| 10 | 2001 | 94 | |
| 11 | 1999 | 18 | |
| 12 | 1998 | 12 |
About Erik van Meegen
Erik van Meegen is a scholar working on Internal Medicine, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 12 papers that have together received 466 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Blood Pressure and Hypertension Studies (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Vitamin K Research Studies (3 papers), Veterinary Pharmacology and Anesthesia (1 paper), Poisoning and overdose treatments (1 paper) and Pharmacology and Obesity Treatment (1 paper). The work is most often cited by research in Internal Medicine (102 citations), Pharmacology (217 citations) and Cardiology and Cardiovascular Medicine (245 citations). Erik van Meegen has collaborated with scholars based in Netherlands, United States and Greece. Frequent co-authors include Bruno H. Stricker, Frits R. Rosendaal, F.J.M. van der Meer, Frits R. Rosendaal, Fernie J. A. Penning‐van Beest, Tom Schalekamp, Anthonius de Boer, Toine C. G. Egberts, Janine Roijers and E. M. van Wijk. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Thrombosis and Haemostasis, British Journal of Haematology, Blood Coagulation & Fibrinolysis and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.